April 30, 2018 / 10:13 AM / 7 months ago

BRIEF-United Therapeutics To Acquire SteadyMed For $4.46 Per Share In Cash

April 30 (Reuters) - Steadymed Ltd:

* UNITED THERAPEUTICS TO ACQUIRE STEADYMED LTD.

* STEADYMED LTD - DEAL FOR $4.46 PER SHARE IN CASH

* STEADYMED - DEAL INCLUDES ADDITIONAL $2.63/SHARE IN CASH TO UNITED THERAPEUTICS UPON ACHIEVEMENT OF MILESTONE RELATED TO COMMERCIALIZATION OF TREVYENT

* STEADYMED LTD - TRANSACTION, INCLUDING $75 MILLION IN CONTINGENT CONSIDERATION, IS VALUED AT $216 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below